Latest (61) Full Text Articles (1570) Focus on Nutrition Article Summary

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: A phase IIb trial
Gastroenterology, 01/24/2014  Clinical Article

Zeuzem S, et al. – The authors performed a phase IIb, randomized, double–blind, placebo–controlled trial to evaluate the efficacy and safety of the combination of simeprevir, peginterferon–α2a (PegIFN), and ribavirin (RBV) in patients with hepatitis C virus (HCV) genotype–1 infection previously treated with PegIFN and RBV. In treatment–experienced patients, 12, 24, or 48 weeks simeprevir (100 mg or 150 mg once daily) in combination with 48 weeks PegIFN and RBV significantly increased rates of SVR at 24 weeks compared with patients given placebo, PegIFN, and RBV and was generally well tolerated.

Methods

  • The authors analyzed data from patients who did not respond (null response), had a partial response, or relapsed after treatment with PegIFN and RBV, randomly assigned to receive simeprevir (100 or 150 mg, once daily) for 12, 24, or 48 weeks plus PegIFN and RBV for 48 weeks (n = 396), or placebo plus PegIFN and RBV for 48 weeks (n = 66).
  • All patients were followed for 24 weeks after planned end of treatment; the primary end point was the proportion of patients with sustained virologic response (SVR; undetectable HCV RNA) at that time point.

Results

  • Overall, rates of SVR at 24 weeks were significantly higher in the groups given simeprevir than those given placebo (61%-80% vs 23%; P < .001), regardless of prior response to PegIFN and RBV (simeprevir vs placebo: prior null response, 38%-59% vs 19%; prior partial response, 48%-86% vs 9%; prior relapse, 77%-89% vs 37%).
  • All groups had comparable numbers of adverse events; these led to discontinuation of simeprevir or placebo and/or PegIFN and RBV in 8.8% of patients given simeprevir and 4.5% of those given placebo.

► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from PDR - powered by MDLinx

Most Popular Gastroenterology Articles

Last month's top read Top Articles of 2014

1 Detox diets for toxin elimination and weight management: a critical review of the evidence Journal of Human Nutrition and Dietetics, December 19, 2014    Review Article

2 Fungal microbiota and digestive diseases Alimentary Pharmacology and Therapeutics, March 5, 2014    Review Article

3 Budesonide foam induces remission in patients with mild-moderate ulcerative proctitis and ulcerative proctosigmoiditis Gastroenterology, February 6, 2015    Clinical Article

4 Crohn's disease management after intestinal resection: a randomised trial The Lancet, January 7, 2015    Evidence Based Medicine    Clinical Article

5 Accuracy of rapid fecal calprotectin test in monitoring inflammatory bowel diseases under treatment with TNFα antagonists Digestive Diseases and Sciences, December 9, 2014    Clinical Article

6 Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes Full Text BMC Gastroenterology, February 12, 2015    Free full text    Clinical Article

7 Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study United European Gastroenterology Journal, February 17, 2015    Clinical Article

8 Cytomegalovirus and inflammatory bowel disease Alimentary Pharmacology and Therapeutics, February 24, 2015    Review Article

9 The dirty side of soap UC San Diego Health System, November 19, 2014

10 Use of antibiotics in patients with Crohn's disease: A systematic review and meta-analysis Journal of Digestive Diseases, December 4, 2014    Evidence Based Medicine    Review Article

11 Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation Clinical Gastroenterology and Hepatology , January 17, 2014    Clinical Article

12 Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: A meta-analysis Clinical Gastroenterology and Hepatology , September 26, 2014    Evidence Based Medicine

13 Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies Alimentary Pharmacology and Therapeutics, January 26, 2015    Clinical Article

14 Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial Gut, January 14, 2015    Clinical Article

15 High prevalence of vitamin A deficiency in Crohn's disease patients according to serum retinol levels and the relative dose-response test Full Text World Journal of Gastroenterology, February 9, 2015    Free full text    Clinical Article

16 Dietary intake of flavonoids and oesophageal and gastric cancer: Incidence and survival in the United States of America (USA) British Journal of Cancer, February 20, 2015    Clinical Article

17 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis Clinical Gastroenterology and Hepatology , September 25, 2014    Clinical Article

18 Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: Findings from the national health and nutrition examination surveys from 1988 to 2012 The American Journal of Gastroenterology, February 16, 2015    Clinical Article

19 Diet in the pathogenesis and treatment of inflammatory bowel diseases Gastroenterology, January 29, 2015    Review Article

20 Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials Digestive and Liver Diseases, February 11, 2015    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Other Topics in Gastroenterology

Register now to view all our site's content (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from our site and our sponsors
View Samples and Register